These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30565854)

  • 1. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
    Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
    Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
    J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial.
    Ramberg C; Hindberg K; Biedermann JS; Cannegieter SC; van der Meer FJ; Snir O; Leebeek FWG; Kruip MJHA; Hansen JB; Lijfering WM
    J Thromb Haemost; 2022 Apr; 20(4):877-887. PubMed ID: 34953155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin use improves measures of coagulation in patients with venous thrombosis.
    Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; Leebeek FWG; Cannegieter SC; Lijfering WM
    Eur Heart J; 2018 May; 39(19):1740-1747. PubMed ID: 29394348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review.
    Orsi FA; Cannegieter SC; Lijfering WM
    Semin Thromb Hemost; 2019 Nov; 45(8):825-833. PubMed ID: 31096309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials.
    Joseph P; Glynn R; Lonn E; Ramasundarahettige C; Eikelboom J; MacFadyen J; Ridker P; Yusuf S
    Cardiovasc Res; 2022 Feb; 118(3):897-903. PubMed ID: 33705531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility.
    Delluc A; Ghanima W; Kovacs MJ; Shivakumar S; Kahn SR; Sandset PM; Kearon C; Mallick R; Rodger MA
    J Thromb Haemost; 2022 Jan; 20(1):126-132. PubMed ID: 34564938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.
    Adams NB; Lutsey PL; Folsom AR; Herrington DH; Sibley CT; Zakai NA; Ades S; Burke GL; Cushman M
    J Thromb Haemost; 2013 Jun; 11(6):1078-84. PubMed ID: 23565981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant decrease in plasmad-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism.
    Alirezaei T; Sattari H; Irilouzadian R
    Clin Cardiol; 2022 Jul; 45(7):717-722. PubMed ID: 35481712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial.
    Schol-Gelok S; de Maat MPM; Biedermann JS; van Gelder T; Leebeek FWG; Lijfering WM; van der Meer FJM; Rijken DC; Versmissen J; Kruip MJHA
    Br J Haematol; 2020 Sep; 190(6):916-922. PubMed ID: 32301122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Chantarangkul V; Cosmi B; Palareti G; Mannucci PM
    J Thromb Haemost; 2008 Aug; 6(8):1327-33. PubMed ID: 18485081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for primary prevention of venous thromboembolism.
    Li L; Zhang P; Tian JH; Yang K
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008203. PubMed ID: 25518837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
    Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Lemma L; Cosmi B; Palareti G; Chantarangkul V; Mannucci PM
    J Thromb Thrombolysis; 2010 Aug; 30(2):215-9. PubMed ID: 20419336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
    Glynn RJ; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; MacFadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Ridker PM
    N Engl J Med; 2009 Apr; 360(18):1851-61. PubMed ID: 19329822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for primary prevention of venous thromboembolism.
    Li L; Sun T; Zhang P; Tian J; Yang K
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008203. PubMed ID: 22161421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial.
    Biedermann JS; Cannegieter SC; Roest M; van der Meer FJ; Reitsma PH; Kruip MJ; Lijfering WM
    J Thromb Haemost; 2016 Jul; 14(7):1404-9. PubMed ID: 27094802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and prevention of venous thromboembolism: Myth or reality?
    Gaertner S; Cordeanu EM; Nouri S; Mirea C; Stephan D
    Arch Cardiovasc Dis; 2016 Mar; 109(3):216-22. PubMed ID: 26778087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis.
    Birdal O; Saygı M; Doğan R; Tezen O; Karagöz A; Tanboğa İH
    Balkan Med J; 2023 Sep; 40(5):324-332. PubMed ID: 37519020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism.
    Wang TF; Waller AP; Lin E; Wei L; Bartosic A; Riedl K; Kerlin BA
    Blood Coagul Fibrinolysis; 2021 Jan; 32(1):16-22. PubMed ID: 33196511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.